PATENT CLAIM ANALYSIS

Application Number: 15982038
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "249000"]

Abstract:
The present invention provides compounds of Formula (I): or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.

Claim (Index 8):
The compound of  claim 6  having Formula (VIII): or a stereoisomer, tautomer, pharmaceutically acceptable salt thereof, wherein:\n K and R are independently selected from the group consisting of: N and CR 5 ; \n R 1b  is H or F; \n R 2  is independently selected from the group consisting of: H, F, CF 3 , C(O)Me, and tetrazole; \n R 3  is selected from the group consisting of: phenyl and indazole; \n R 5  is selected from the group consisting of: H and R 8 ; \n R 8  is selected from the group consisting of: phenyl and 5- to 10-membered heterocycle containing carbon atoms and 1-4 heteroatoms selected from the group consisting of N, NR a , O, and S; wherein said carbocycle or heterocycle is substituted with 0-3 R b ; \n R a  is H, or C 1-4  alkyl; and \n R b  is selected from the group consisting of: C 1-4  alkyl, C 1-4  alkoxy, and CONH 2 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 93.0
- Lexical Diversity: 1.17949
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15643891', '15183051', '14799681', '14350411', '14350417']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8310346967341803
- 35 USC 102 Novelty (BERT): 0.5160594248399957
- Combined Prediction Score: 0.7995371695447618
- Mean Citation Score: 315.033496
- Max Citation Score: 316.3271200000001
- Similarity Product: 245.868437877369

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test